For: | Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF, Huang Q, Fang GQ, Li EM. MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17(1): 79-88 [PMID: 21218087 DOI: 10.3748/wjg.v17.i1.79] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i1/79.htm |
Number | Citing Articles |
1 |
Rui‐Jun Lin, Da‐Wei Xiao, Lian‐Di Liao, Tao Chen, Ze‐Feng Xie, Wei‐Zhe Huang, Wei‐Sen Wang, Tai‐Feng Jiang, Bing‐Li Wu, En‐Min Li, Li‐Yan Xu. MiR‐142‐3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Journal of Surgical Oncology 2012; 105(2): 175 doi: 10.1002/jso.22066
|
2 |
Leila Karimi, Behzad Mansoori, Dariush shanebandi, Ali Mohammadi, Mahyar Aghapour, Behzad Baradaran. Function of microRNA-143 in different signal pathways in cancer: New insights into cancer therapy. Biomedicine & Pharmacotherapy 2017; 91: 121 doi: 10.1016/j.biopha.2017.04.060
|
3 |
Ling Gao, Wenhao Ren, Su‘e Chang, Bo Guo, Shuo Huang, Menghe Li, Youmin Guo, Zongfang Li, Tusheng Song, Keqian Zhi, Chen Huang. Downregulation of miR-145 Expression in Oral Squamous Cell Carcinomas and Its Clinical Significance. Oncology Research and Treatment 2013; 36(4): 194 doi: 10.1159/000349956
|
4 |
Vahid Asghariazar, Behzad Mansoori, Mahtab Kadkhodayi, Elham Safarzadeh, Ali Mohammadi, Behzad Baradaran, Ebrahim Sakhinia. MicroRNA-143 act as a tumor suppressor microRNA in human lung cancer cells by inhibiting cell proliferation, invasion, and migration. Molecular Biology Reports 2022; 49(8): 7637 doi: 10.1007/s11033-022-07580-1
|
5 |
Yini Ma, Xiu Cao, Guojuan Shi , Tianlu Shi. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target. Current Pharmaceutical Design 2021; 27(19): 2264 doi: 10.2174/1381612826666201029095702
|
6 |
Qiong Zhang, Huaiyong Gan, Wenqing Song, Damin Chai, Shiwu Wu. MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5. Scandinavian Journal of Gastroenterology 2018; 53(7): 769 doi: 10.1080/00365521.2018.1476913
|
7 |
SEN JIANG, CHAO ZHAO, XIAODI YANG, XIANGYANG LI, QING PAN, HAIJIN HUANG, XUYANG WEN, HUSHENG SHAN, QIANWEN LI, YUNXIANG DU, YAPING ZHAO. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression. International Journal of Molecular Medicine 2016; 38(1): 113 doi: 10.3892/ijmm.2016.2619
|
8 |
Aylin Orgen Calli, Kerem Kurt, Gizem Narli, Duygu Unal Kocabey, Alpay Yilmaz, Irfan Ocal, Seyran Yigit, Ismail Yilmaz. Are micro-RNA 21 and 143 indicative as prognostic biomarkers in dedifferentiated endometrial adenocarcinoma?. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09663-7
|
9 |
Priyanka Sharma, Rinu Sharma. miRNA–mRNA crosstalk in esophageal cancer: From diagnosis to therapy. Critical Reviews in Oncology/Hematology 2015; 96(3): 449 doi: 10.1016/j.critrevonc.2015.07.002
|
10 |
Han‐Jie Zhang, Gang Chen, Shang‐Wei Chen, Zong‐Wang Fu, Hua‐Fu Zhou, Zhen‐Bo Feng, Jun‐Xian Mo, Chang‐Bo Li, Jun Liu. Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance. FEBS Open Bio 2021; 11(11): 3126 doi: 10.1002/2211-5463.13306
|
11 |
Mingxin Zhang, Suna Zhou, Lingmin Zhang, Jia Zhang, Hui Cai, Jinxiang Zhu, Chen Huang, Jiansheng Wang. Retracted: miR‐518b is down‐regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Letters 2012; 586(19): 3508 doi: 10.1016/j.febslet.2012.08.007
|
12 |
Li-Li Mei, Wen-Jun Wang, Yun-Tan Qiu, Xiu-Feng Xie, Jie Bai, Zhi-Zhou Shi. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences 2017; 18(9): 1833 doi: 10.3390/ijms18091833
|
13 |
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, Tatiana Correa Carneiro-Lobo, Sabah Akhtar, Kodappully Sivaraman Siveen, Nissar A. Wani, Arshi Rizwan, Puneet Bagga, Mayank Singh, Ravinder Reddy, Shahab Uddin, Jean-Charles Grivel, Gyan Chand, Michael P. Frenneaux, Mushtaq A. Siddiqi, Davide Bedognetti, Wael El-Rifai, Muzafar A. Macha, Mohammad Haris. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-020-01294-3
|
14 |
Shi‐Yun Cui, Rui Wang, Long‐Bang Chen. MicroRNA‐145: a potent tumour suppressor that regulates multiple cellular pathways. Journal of Cellular and Molecular Medicine 2014; 18(10): 1913 doi: 10.1111/jcmm.12358
|
15 |
Yu Mao, Jia Liu, Dakai Zhang, Baosheng Li. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma. Tumor Biology 2016; 37(7): 9009 doi: 10.1007/s13277-015-4760-9
|
16 |
Rosa Hernández, Ester Sánchez-Jiménez, Consolación Melguizo, Jose Prados, Ana Rosa Rama. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Reports 2018; 51(11): 563 doi: 10.5483/BMBRep.2018.51.11.116
|
17 |
Guanghui Cui, Donglei Liu, Weihao Li, Yuhang Li, Youguang Liang, Wensong Shi, Song Zhao. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells. Experimental Biology and Medicine 2017; 242(1): 45 doi: 10.1177/1535370216662712
|
18 |
Jin-Hui Chen, Rui Yang, Wei Zhang, Yong-Ping Wang. Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma. Experimental and Therapeutic Medicine 2016; 12(6): 3749 doi: 10.3892/etm.2016.3847
|
19 |
Keiko Mizuno, Hiroko Mataki, Naohiko Seki, Tomohiro Kumamoto, Kazuto Kamikawaji, Hiromasa Inoue. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis. Journal of Human Genetics 2017; 62(1): 57 doi: 10.1038/jhg.2016.98
|
20 |
Xiaobo Li, Caitlin Wainscott, Yaguang Xi. MicroRNA provides insight into understanding esophageal cancer. Thoracic Cancer 2011; 2(4): 134 doi: 10.1111/j.1759-7714.2011.00059.x
|
21 |
P. Bus, P. D. Siersema, R. E. Verbeek, J. W. P. M. van Baal. Upregulation of miRNA-143, -145, -192, and -194 in esophageal epithelial cells upon acidic bile salt stimulation. Diseases of the Esophagus 2014; 27(6): 591 doi: 10.1111/dote.12112
|
22 |
Su-Na Zhou. Role of non-coding RNAs in esophageal carcinoma. World Chinese Journal of Digestology 2020; 28(12): 453 doi: 10.11569/wcjd.v28.i12.453
|
23 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
24 |
Xiaodong Wu, Li‐Yan Xu, En‐Min Li, Geng Dong. Molecular dynamics simulation study on the structures of fascin mutants. Journal of Molecular Recognition 2023; 36(1) doi: 10.1002/jmr.2998
|
25 |
Stefan David, Stephen J Meltzer. MicroRNA involvement in esophageal carcinogenesis. Current Opinion in Pharmacology 2011; 11(6): 612 doi: 10.1016/j.coph.2011.09.006
|
26 |
Lixia Shi, Qing Chen, Xiaofen Ge. Long intergenic non‐coding RNA 00337 confers progression of esophageal cancer by mediating microrna‐145‐dependent fscn1. The FASEB Journal 2020; 34(9): 11431 doi: 10.1096/fj.202000470
|
27 |
Hai-Feng Zhang, Abdulraheem Alshareef, Chengsheng Wu, Ji-Wei Jiao, Poul H. Sorensen, Raymond Lai, Li-Yan Xu, En-Min Li. miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma. Carcinogenesis 2016; 37(9): 858 doi: 10.1093/carcin/bgw079
|
28 |
|
29 |
Fang Zhang, Zhiping Yang, Minjun Cao, Yinsheng Xu, Jintao Li, Xuebin Chen, Zhi Gao, Jing Xin, Shaomei Zhou, Zhixiang Zhou, Yishu Yang, Wang Sheng, Yi Zeng. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Letters 2014; 342(1): 121 doi: 10.1016/j.canlet.2013.08.037
|
30 |
Emmanuel I. Papadopoulos, Andreas Scorilas. Cisplatin and Paclitaxel Alter the Expression Pattern of miR‐143/145 and miR‐183/96/182 Clusters in T24 Bladder Cancer Cells. Clinical and Translational Science 2015; 8(6): 668 doi: 10.1111/cts.12323
|
31 |
Mona Fendereski, Mohammad Farid Zia, Mohammad Shafiee, Forousan Safari, Mohammad Hosien Saneie, Manoochehr Tavassoli. MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma. Cancer Investigation 2017; 35(2): 78 doi: 10.1080/07357907.2016.1254228
|
32 |
Qing Chen, Juan Hou, Zhiwei Wu, Jie Zhao, De Ma. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Pathology - Research and Practice 2019; 215(7): 152427 doi: 10.1016/j.prp.2019.04.019
|
33 |
CHUNYANG ZHAO, YAN XU, YONGQIANG ZHANG, WEIWEI TAN, JIANXIN XUE, ZONGZE YANG, YOU ZHANG, YOU LU, XUN HU. Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases. Oncology Reports 2013; 30(5): 2027 doi: 10.3892/or.2013.2728
|
34 |
Mohammad Hossein Ansari, Shiva Irani, Houri Edalat, Ruhul Amin, Amaneh Mohammadi Roushandeh. Deregulation of miR-93 and miR-143 in human esophageal cancer. Tumor Biology 2016; 37(3): 3097 doi: 10.1007/s13277-015-3987-9
|
35 |
Li‑Li Mei, Yun‑Tan Qiu, Wen‑Jun Wang, Jie Bai, Zhi‑Zhou Shi. Overexpression of microRNA‑1470 promotes proliferation and migration, and inhibits senescence of esophageal squamous carcinoma cells. Oncology Letters 2017; doi: 10.3892/ol.2017.7190
|
36 |
Deyuan Pan, Lin Long, Chengyu Li, Yingxin Zhou, Qing Liu, Ziting Zhao, Hui Zhao, Wan Lin, Zhenyuan Zheng, Liu Peng, Enmin Li, Liyan Xu. Splicing factor hnRNPA1 regulates alternative splicing of LOXL2 to enhance the production of LOXL2Δ13. Journal of Biological Chemistry 2024; 300(7): 107414 doi: 10.1016/j.jbc.2024.107414
|
37 |
Xiaoming Zhang, Ying Dong, Hongjuan Ti, Jing Zhao, Ying Wang, Ting Li, Bo Zhang. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas. Human Pathology 2013; 44(11): 2571 doi: 10.1016/j.humpath.2013.07.002
|
38 |
Li-Li Mei, Yun-Tan Qiu, Meng-Bing Huang, Wen-Jun Wang, Jie Bai, Zhi-Zhou Shi. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Cancer Biomarkers 2017; 20(4): 527 doi: 10.3233/CBM-170345
|
39 |
Ashleigh E. Moore, Lisa E. Young, Dan A. Dixon. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer and Metastasis Reviews 2011; 30(3-4): 419 doi: 10.1007/s10555-011-9300-5
|
40 |
Sikhumbuzo Mbatha, Rodney Hull, Zodwa Dlamini. Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. Biomedicines 2022; 10(10): 2359 doi: 10.3390/biomedicines10102359
|
41 |
Xiaodong Wu, Bing Wen, Lirui Lin, Wenqi Shi, Dajia Li, Yinwei Cheng, Li-Yan Xu, En-Min Li, Geng Dong. New insights into the function of Fascin in actin bundling: A combined theoretical and experimental study. The International Journal of Biochemistry & Cell Biology 2021; 139: 106056 doi: 10.1016/j.biocel.2021.106056
|
42 |
Sichuan Xi, Shakirat Oyetunji, Haitao Wang, Said Azoury, Yi Liu, Shih-Hsin Hsiao, Mary Zhang, Shamus R. Carr, Chuong D. Hoang, Haobin Chen, David S. Schrump. Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2. Laboratory Investigation 2023; 103(4): 100014 doi: 10.1016/j.labinv.2022.100014
|
43 |
Wen-Jian Liu, Yuan Zhao, Xu Chen, Man-Li Miao, Ren-Quan Zhang. Epigenetic modifications in esophageal cancer: An evolving biomarker. Frontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1087479
|
44 |
M. Odenthal, E. Bollschweiler, P.P. Grimminger, W. Schröder, J. Brabender, U. Drebber, A.H. Hölscher, R. Metzger, D. Vallböhmer. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR‐192 in prediction of multimodality therapy response. International Journal of Cancer 2013; 133(10): 2454 doi: 10.1002/ijc.28253
|
45 |
Naomi S. Sakai, Emma Samia-Aly, Mariagnese Barbera, Rebecca C. Fitzgerald. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Seminars in Cancer Biology 2013; 23(6): 512 doi: 10.1016/j.semcancer.2013.08.005
|
46 |
Toshiyuki Ishiwata, Yoko Matsuda, Hisashi Yoshimura, Norihiko Sasaki, Shunji Ishiwata, Naoshi Ishikawa, Kaiyo Takubo, Tomio Arai, Junko Aida. Pancreatic cancer stem cells: features and detection methods. Pathology & Oncology Research 2018; 24(4): 797 doi: 10.1007/s12253-018-0420-x
|
47 |
Feng Wang, Jin Xia, Nengchao Wang, Hong Zong. miR-145 Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma in Part by Targeting c-Myc. Onkologie 2013; 36(12): 754 doi: 10.1159/000356978
|
48 |
Yan Wang, Jinnan Zhang, Wei Zhao, Donglin Wang, Wenduan Ma, Shengtao Shang, Chao Feng, Haixin Yu. MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers. Molecular Medicine Reports 2017; 15(6): 3833 doi: 10.3892/mmr.2017.6479
|
49 |
Maria Hatziapostolou, Christos Polytarchou, Dimitrios Iliopoulos. miRNAs link metabolic reprogramming to oncogenesis. Trends in Endocrinology & Metabolism 2013; 24(7): 361 doi: 10.1016/j.tem.2013.03.002
|
50 |
Saira R. Ali, Karen J. Humphreys, Ross A. McKinnon, Michael Z. Michael. Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review. Drug Development Research 2015; 76(6): 296 doi: 10.1002/ddr.21268
|
51 |
Shibai Yi, Danqi Lu, Wan Peng, Ting Wang, Yong Zhang, Haoran Lin, Uwe Fischer. Differential Expression Profiling of Spleen MicroRNAs in Response to Two Distinct Type II Interferons in Tetraodon nigroviridis. PLoS ONE 2014; 9(5): e96336 doi: 10.1371/journal.pone.0096336
|
52 |
Jun He, Xu Qian, Richard Carpenter, Qing Xu, Lin Wang, Yanting Qi, Zi-Xuan Wang, Ling-Zhi Liu, Bing-Hua Jiang. Repression of miR-143 Mediates Cr (VI)–Induced Tumor Angiogenesis via IGF-IR/IRS1/ERK/IL-8 Pathway. Toxicological Sciences 2013; 134(1): 26 doi: 10.1093/toxsci/kft101
|
53 |
Jun Kiuchi, Shuhei Komatsu, Taisuke Imamura, Keiji Nishibeppu, Katsutoshi Shoda, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Kazuma Okamoto, Hitoshi Fujiwara, Daisuke Ichikawa, Eigo Otsuji. Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-018-0929-3
|
54 |
Dan A. Dixon, Fernando F. Blanco, Annalisa Bruno, Paola Patrignani. Prospects for Chemoprevention of Colorectal Neoplasia. Recent Results in Cancer Research 2013; 191: 7 doi: 10.1007/978-3-642-30331-9_2
|
55 |
Qiang Han, Hua-Yong Zhang, Bei-Long Zhong, Xiao-Jing Wang, Bing Zhang, Hua Chen. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma. Medical Science Monitor 2016; 22: 3925 doi: 10.12659/MSM.897663
|
56 |
Wen Gao, Wei Sun, Jinfeng Yin, Xiaoyang Lv, Jianjun Bao, Jiarui Yu, Lihong Wang, Chengyan Jin, Liang Hu, Meijia Zhang. Screening candidate microRNAs (miRNAs) in different lambskin hair follicles in Hu sheep. PLOS ONE 2017; 12(5): e0176532 doi: 10.1371/journal.pone.0176532
|
57 |
S.-Q. Li, F.-J. Chen, X.-F. Cao. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment. Diseases of the Esophagus 2013; 26(3): 288 doi: 10.1111/j.1442-2050.2012.01346.x
|
58 |
Kun Zhou, Yan Yan, Song Zhao. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122. Tumor Biology 2014; 35(6): 5787 doi: 10.1007/s13277-014-1768-5
|
59 |
Jia-Xing Zhang, Zhen-Hua Chen, Yi Xu, Jie-Wei Chen, Hui-Wen Weng, Miao Yun, Zou-San Zheng, Cui Chen, Bing-Li Wu, En-Min Li, Jian-Hua Fu, Sheng Ye, Dan Xie. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2. Clinical Cancer Research 2017; 23(1): 298 doi: 10.1158/1078-0432.CCR-16-0414
|
60 |
Wang-Kai Fang, Lian-Di Liao, Li-Yan Li, Yang-Min Xie, Xiu-E Xu, Wei-Jiang Zhao, Jian-Yi Wu, Meng-Xiao Zhu, Zhi-Yong Wu, Ze-Peng Du, Bing-Li Wu, Dong Xie, Ming-Zhou Guo, Li-Yan Xu, En-Min Li. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma. The Journal of Pathology 2013; 231(2): 257 doi: 10.1002/path.4236
|
61 |
Ya-Qiong Tian, Zhi-Juan Fan, Shuang Liu, Yu-Jing Wu, Shu-Ye Liu. Value of microRNAs in diagnosis and prognosis of colorectal cancer. World Chinese Journal of Digestology 2019; 27(20): 1278 doi: 10.11569/wcjd.v27.i20.1278
|
62 |
Ai Jia, Yue Wu, Wanli Ren, Peng Han, Yuan Shao. Genetic variations of CARMN affect risk of esophageal cancer in northwest China. Gene 2020; 748: 144680 doi: 10.1016/j.gene.2020.144680
|
63 |
CHANG LIU, PING DUAN, BO LI, CHUNTIAN HUANG, YING JING, WENHAI YAN. miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1. Oncology Letters 2015; 9(1): 96 doi: 10.3892/ol.2014.2678
|
64 |
Hai-Feng Zhang, Abdulraheem Alshareef, Chengsheng Wu, Shang Li, Ji-Wei Jiao, Hui-Hui Cao, Raymond Lai, Li-Yan Xu, En-Min Li. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Oncotarget 2015; 6(30): 28949 doi: 10.18632/oncotarget.5027
|
65 |
Qin-Yan Gao, Jing-Yuan Fang. Early esophageal cancer screening in China. Best Practice & Research Clinical Gastroenterology 2015; 29(6): 885 doi: 10.1016/j.bpg.2015.09.018
|
66 |
Su Q. Li, He M. Wang, Xiu F. Cao. Potential clinical insights into microRNAs and their target genes in esophageal carcinoma. Biomarkers 2011; 16(8): 629 doi: 10.3109/1354750X.2011.608132
|
67 |
Pedro M. Borralho, André E. S. Simões, Sofia E. Gomes, Raquel T. Lima, Tânia Carvalho, Duarte M. S. Ferreira, Maria H. Vasconcelos, Rui E. Castro, Cecília M. P. Rodrigues, Reiner Albert Veitia. miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation. PLoS ONE 2011; 6(8): e23787 doi: 10.1371/journal.pone.0023787
|
68 |
Nazila Nouraee, Katrien Van Roosbroeck, Mohammad Vasei, Shahriar Semnani, Nader Mansour Samaei, Farshad Naghshvar, Abbas Ali Omidi, George A. Calin, Seyed Javad Mowla, Claudia Daniela Andl. Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma. PLoS ONE 2013; 8(9): e73009 doi: 10.1371/journal.pone.0073009
|
69 |
Peter Y Yu, Mumtaz Y Balkhi, Katherine J Ladner, Hansjuerg Alder, Lianbo Yu, Xiaokui Mo, William G Kraybill, Denis C Guttridge, O Hans Iwenofu. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas. Laboratory Investigation 2016; 96(4): 481 doi: 10.1038/labinvest.2015.168
|
70 |
Hai-Feng Zhang, Kai Zhang, Lian-Di Liao, Li-Yan Li, Ze-Peng Du, Bing-Li Wu, Jian-Yi Wu, Xiu-E Xu, Fa-Min Zeng, Bo Chen, Hui-Hui Cao, Meng-Xiao Zhu, Li-Hua Dai, Lin Long, Zhi-Yong Wu, Raymond Lai, Li-Yan Xu, En-Min Li. miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis 2014; 35(2): 292 doi: 10.1093/carcin/bgt320
|
71 |
Fernando F. Blanco, Noémie Legrand, Cyril Sobolewski, Dan A. Dixon. Post-transcriptional Mechanisms in Endocrine Regulation. 2016; : 181 doi: 10.1007/978-3-319-25124-0_9
|
72 |
Yang Ni, Long Meng, Liguang Wang, Wei Dong, Hongchang Shen, Guanghui Wang, Qi Liu, Jiajun Du. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 2013; 517(2): 197 doi: 10.1016/j.gene.2012.12.031
|
73 |
Hai Long Fu, De Ping Wu, Xiu Fang Wang, Jian Guo Wang, Feng Jiao, Lei Lei Song, Hui Xie, Xu Yang Wen, Hu Sheng Shan, Yun Xiang Du, Ya Ping Zhao. Altered miRNA Expression is Associated with Differentiation, Invasion, and Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) in Patients from Huaian, China. Cell Biochemistry and Biophysics 2013; 67(2): 657 doi: 10.1007/s12013-013-9554-3
|
74 |
Ying-Ying Jin, Qing-Juan Chen, Yang Wei, Ya-Li Wang, Zhong-Wei Wang, Kun Xu, Yun He, Hong-Bing Ma. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma. Journal of Radiation Research 2016; 57(5): 468 doi: 10.1093/jrr/rrw068
|
75 |
Ping Zhou, He Dong, Shuqian He, Lei Fang, Nan Jiang, Qing Sun. miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53. Molecular Medicine Reports 2017; 16(2): 1855 doi: 10.3892/mmr.2017.6808
|
76 |
Tai-Chung Huang, Santosh Renuse, Sneha Pinto, Praveen Kumar, Yi Yang, Raghothama Chaerkady, Brian Godsey, Joshua T. Mendell, Marc K. Halushka, Curt I. Civin, Luigi Marchionni, Akhilesh Pandey. Identification of miR-145 targets through an integrated omics analysis. Molecular BioSystems 2015; 11(1): 197 doi: 10.1039/C4MB00585F
|
77 |
Kohei Taniguchi, Shun-ichi Wada, Yuko Ito, Junsuke Hayashi, Yosuke Inomata, Sang-Woong Lee, Tomohito Tanaka, Kazumasa Komura, Yukihiro Akao, Hidehito Urata, Kazuhisa Uchiyama. α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro. Molecular Pharmaceutics 2019; 16(11): 4542 doi: 10.1021/acs.molpharmaceut.9b00680
|
78 |
Wenbo Fu, Lijuan Pang, Yunzhao Chen, Lan Yang, Janbo Zhu, Yutao Wei. The MicroRNAs as Prognostic Biomarkers for Survival in Esophageal Cancer: A Meta-Analysis. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/523979
|
79 |
Bingli Wu, Chunquan Li, Pixian Zhang, Qianlan Yao, Jianyi Wu, Junwei Han, Liandi Liao, Yanjun Xu, Ruijun Lin, Dawei Xiao, Liyan Xu, Enmin Li, Xia Li, Xin-Yuan Guan. Dissection of miRNA-miRNA Interaction in Esophageal Squamous Cell Carcinoma. PLoS ONE 2013; 8(9): e73191 doi: 10.1371/journal.pone.0073191
|